Viewing nowFosioled 10 mg Tablet (Dapagliflozin Propanediol Hydrate)
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 202202227 · Approved 2022.05.25 · Insurance code 649405670
Improvement of blood glucose control in type 2 diabetes mellitus
This drug is used to help control blood sugar in patients with type 2 diabetes. It can be administered alone or in combination with dietary and exercise therapy. It can also be safely used in patients with cardiovascular diseases or risk factors among those whose blood sugar control is insufficient, with information related to cardiovascular events available in professional guidelines. This drug improves blood sugar control and helps manage the health of patients with type 2 diabetes.
Monotherapy and add-on combination therapy The recommended dose of this medicine is 10mg once daily for monotherapy and add-on combination therapy with other glucose-lowering agents, including insulin. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. Initial combination therapy For patients who have not previously received drug treatment for diabetes, when this medicine is administered with metformin, the recommended initial dose is 5mg once daily or 10mg once daily. Special populations Renal impairment - eGFR less than 45 mL/min/1.73m2: Use of this medicine to improve glycemic control is not recommended. - Patients receiving dialysis: Do not administer this medicine. Hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment. For patients with severe hepatic impairment, an initial dose of 5mg is recommended. If well tolerated, this dose may be increased to 10mg. Older adults (≥ 65 years) Dose adjustment based on age is not recommended. Method of administration This medicine may be administered orally once daily at any time of day, with or without food. The tablet should be swallowed whole.
The efficacy and safety of dapagliflozin in children under 18 years of age have not been established. No relevant data are available.
This drug should not be used in patients who have allergies to the active ingredient or excipients, or in patients with type 1 diabetes or diabetic ketoacidosis. Patients with lactose intolerance or genetic lactose metabolism disorders, and patients undergoing dialysis should also not take this medication. Patients with low fluid volume or impaired kidney function should use this drug cautiously, and blood pressure and kidney function should be closely monitored before and during administration. This drug may have reduced blood sugar control efficacy in patients with severely impaired kidney function. When taking this medication, there is a possibility of infections such as genital infections or urinary tract infections, which require immediate treatment if symptoms appear. Due to the risk of hypoglycemia, caution should be exercised for those taking it in conjunction with insulin or sulfonylureas, and the dosage of such medications may need to be reduced if necessary. Dehydration or low blood pressure symptoms may occur due to decreased fluid volume, so adequate hydration and monitoring of symptoms is necessary. There is a risk of serious metabolic disorders such as diabetic ketoacidosis; thus, if symptoms like vomiting, abdominal pain, or difficulty breathing occur, immediate consultation with a healthcare provider is essential. Older adults or those taking diuretics are at higher risk for decreased fluid volume and low blood pressure, requiring additional caution. It is recommended that pregnant women and lactating women do not use this drug, and it should be discontinued once pregnancy is confirmed. The safety and efficacy of this drug in children have not been sufficiently established, so use is not advised. In cases of overdose, there are no specific antidotes, and appropriate treatment should be administered based on symptoms, with immediate visit to a medical institution if necessary. This drug does not significantly affect driving or machinery operation, but caution is needed in cases of hypoglycemia. Finally, this medication should be stored in its original container, safely out of reach of children.
Vulvitis, balanitis and related genital infections, urinary tract infections, fungal infections, perineal necrosis, hypoglycemia, decreased fluid volume, thirst, diabetic ketoacidosis, dizziness, constipation, dry mouth, low back pain, dysuria, polyuria, nocturia, interstitial nephritis, vulvar pruritus, genital pruritus, increased hematocrit, reduced renal creatinine clearance at the onset of treatment, dyslipidemia, elevated serum creatinine at the onset of treatment, elevated blood urea, weight loss, acute pyelonephritis, rash, angioedema, malaise, pain, keratitis, chronic obstructive pulmonary disease, hemoptysis, cerebral hemorrhage, peripheral artery occlusion, angina, myocardial infarction, choledocholithiasis, cholangitis, alcoholic cirrhosis, depression, suicide attempt, gastric adenocarcinoma, anaphylactic reaction, dysesthesia, cerebral infarction, nerve compression, chest pain, edema, fever, foreign body sensation, facial edema, facial pain, warmth, flu-like symptoms, breast lump, erectile dysfunction, benign prostatic hyperplasia, breast pain, genital rash, menorrhagia, genital edema, uterine hemorrhage, vaginal bleeding, vulvar discomfort, hair loss, dermatitis, xeroderma, allergic dermatitis, contact dermatitis, diabetic foot ulcer, sweating abnormal eczema, nummular eczema, eczema, hyperkeratosis, nail pigmentation, skin lesions, urticaria, night sweats, arthralgia, musculoskeletal pain, limb pain, muscle weakness, myalgia, osteoarthritis, ligament sprain, diabetic retinopathy, cough, dyspnea, orthostatic hypotension, palpitations, insomnia, fatty liver, gallbladder polyp, tinnitus
Not everyone experiences these, and they can vary from person to person.
This drug may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain storage temperatures between 1 to 30 degrees Celsius to preserve its efficacy and safety over time.
Yellow, flat, diamond-shaped film-coated tablet
28 tablets/box [7 tablets/PTP x 4], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 6.15mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Sung IS Co., Ltd.
Dapagliflozin Propanediol Hydrate
Prescription medication
Optus Pharmaceutical Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Aprogen Biologics Co., Ltd.

Dapagliflozin Propanediol Hydrate 12.3mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.